Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06855290

Tumor Immunity and Cancer Recurrence Prediction Model

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Anhui Provincial Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this observational study is to understand the predictive effect of the laboratory-developed TIMES scoring system on the recurrence status of cancer patients who have undergone surgical tumor resection. The main questions it aims to answer are: Can the TIMES scoring system accurately predict the recurrence status of cancer patients who have undergone surgical tumor resection? What is the accuracy of the TIMES scoring system? The medical records or biological specimens used in this study were obtained from previous clinical treatments, and the tissues used were collected from post-surgical discarded tissues from the participants, which will not affect their health. Researchers will continuously monitor the disease progression of the participants for up to 10 years or until cancer recurrence occurs.

Detailed description

No grouping, the long-term tracking of participants' disease progression and recurrence status will be compared with the analysis results of the collected discarded tumor tissues from the participants' surgeries

Conditions

Timeline

Start date
2025-06-01
Primary completion
2026-11-30
Completion
2026-12-31
First posted
2025-03-03
Last updated
2025-03-03

Source: ClinicalTrials.gov record NCT06855290. Inclusion in this directory is not an endorsement.

Tumor Immunity and Cancer Recurrence Prediction Model (NCT06855290) · Clinical Trials Directory